Metabolic Features of the Reproductive Phenotypes of Polycystic Ovary Syndrome

    January 2009 in “ Human Reproduction Update ”
    Lisa J. Moran, Helena Teede
    Image of study
    TLDR Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.
    In the 2009 study, Lisa Moran and Helena Teede reviewed literature to understand the metabolic differences among various phenotypes of Polycystic Ovary Syndrome (PCOS). They found that the National Institute of Health (NIH) PCOS phenotype, which includes hyperandrogenism and irregular ovulation, is associated with greater obesity, insulin resistance, and higher risk factors for type 2 diabetes and cardiovascular disease compared to non-NIH PCOS phenotypes. The study also indicated that abdominal obesity is a significant factor in the metabolic abnormalities seen in PCOS. Non-hyperandrogenic PCOS phenotypes were found to have similar insulin resistance to ovulatory PCOS when matched for abdominal obesity. The review concluded that all PCOS phenotypes, including non-NIH groups, should be considered subgroups of PCOS due to their metabolic features, with NIH PCOS showing a more adverse metabolic profile. The document also highlighted the need for more research to better understand the metabolic implications of PCOS and to develop targeted screening and treatment strategies.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 19 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 11 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 3 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community PCOS Hair Loss: What’s Helped Me (and What Didn’t)

      in Treatment  10 upvotes 3 days ago
      OP shares their experience with PCOS-related hair loss, highlighting that addressing vitamin D and ferritin deficiencies, managing hormones with spironolactone, and using gentle hair care products helped improve their condition. They advise against relying on "miracle" hair oils and emphasize the importance of medical evaluation and a combined approach to treatment.

    Similar Research

    6 / 1000+ results